Compounding in Dermatology Update – Part 2
In part 1 of this 2-part series, Dr. Kircik along with JDD authors Vlatka Agnetta MD, Abel Torres MD JD MBA, Seemal R. Desai MD, and Adelaide A. Hebert MD, reviewed the regulatory landscape of compounding in dermatology, including federal and state regulations. In part 2, they discuss FDA and USP Compounding Lists/ Categories and provide their final thoughts on in-office compounding. FDA Compound …
Infectious Lesion – Friday Pop Quiz 3/20
This infectious lesion appeared very rapidly after surgery and started as a nodule that now looks like the photograph, what is the treatment of choice after drainage? A. Clindamycin B. Minocycline C. Doxycycline D. Clarithromycin E. No treatment after drainage To find out the correct answer and read the explanation, click here. Brought to you by our brand partner Derm In-Revie …
Hidradenitis Suppurativa (HS): Everything and the Kitchen Sink
Hidradenitis SuppurativaI’ll never forget the stories that my patients told me at our monthly hidradenitis suppurativa support group meetings in the Bronx. From women who were too embarrassed to wear short sleeves to men in so much pain they could not sit down properly, all of them had been impacted profoundly by this disease. That is why I was so excited to cover this lecture at the 2020 ODAC Dermatology, Aesthetic a …
Hidradenitis Suppurativa
Compounding in Dermatology Update – Part 1
Compounding in Dermatology UpdateMedication compounding is defined as any alteration, mixing, or combining of two or more ingredients that make the drug more specific to the needs of the patient.1 Compounded medications are used widely in patient care to meet their individual medical needs and maximize treatment outcomes. The Food and Drug Administration (FDA) and the United States Pharmacopeia (USP) have been the leading organiz …
Compounding in Dermatology Update
Lamotrigine – Friday Pop Quiz 3/6
This 20-year-old woman started lamotrigine 3 weeks ago. She takes no other medications, and has no comorbid conditions. Her urine b-HCG is positive. Which of the following treatments has the theoretically lowest fetal risk? A. Prednisone B. IVIG C. Etanercept D. Cyclosporine E. Rituximab To find out the correct answer and read the explanation, click here. Brought to you by our …